Schedule 13D ownership disclosure

Oasmia Pharmaceutical AB

Security class unavailable

Event date: 2015-10-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
21.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-007947
Form type
SC 13D
Filer
Alceco International S.A.
CIK
CIK 1697518
Filed
Feb 13, 2017
Reporting period
Oct 21, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub